Cyxone has engaged senior scientific experts to support the development of the drug projects. All members of the Scientific Advisory Board are acknowledged experts within their respective fields. They add important experience from both the scientific and industrial areas to Cyxone.
Chairman of the scientific advisory
Christian Gruber is a research group leader and Associate Professor at the Medical University of Vienna (Austria). He studied Biochemistry at the University of Tübingen, Germany, and Molecular Biotechnology at the Queensland University of Technology, Australia, and received a Ph.D. in Molecular Biosciences from The University of Queensland. For his achievements he has received several scientific awards, such as the 2013 Heribert Konzett Award of the Austrian Pharmacological Society, the 2014 Young Investigator Silver Award of the International Union of Basic and Clinical Pharmacology, and the 2014 Dr. Willmar Schwabe Award of the Society for Medicinal Plant and Natural Product Research. The research focus of his team is to study biological function sand pharmacological mechanisms of nature-derived peptides isolated from plants and invertebrates (e.g. peptide hormones, neuropeptides and peptide toxins), and the development of novel peptide therapeutics. He is a member of the scientific affairs committee of the European Peptide Society and member elect of the Max-Bergmann-Kreis.
Maarten Kraan holds a medical degree and a Ph.D. in immunology from Leiden University, The Netherlands, and a board certification in Rheumatology. During his academic career he worked at Leiden University and as associate professor at the University of Amsterdam. He has held several management positions within drug research, clinical development and regulatory affairs in pharmaceutical companies in both Europe and USA. Maarten is Senior Medical Advisor at AM Pharma, CMO at Citryll and board member of Toleranzia AB.
Rikard Holmdahl has long established experience and expert knowledge in immunology and autoimmune diseases. Professor Holmdahl is one of Sweden’s leading scientists in immunology who has contributed to very valuable insights into the mechanisms causing chronic inflammatory diseases such as multiple sclerosis and rheumatoid arthritis. He has during his career been acknowledged with several prestigious scientific prizes for his pioneering research. Professor Holmdahl is a member of the Royal Swedish Academy of Sciences and has also been part of the Nobel Assembly between 2014 and 2021. Since 2008, Holmdahl has led a world-leading team of scientists in inflammatory diseases at Karolinska Institute (KI) and has been one of the leading scientists behind the discovery of Cyxone’s drug candidate rabeximod.